In This Section

Global Scholar-in-Training Awards Recipients

The American Association for Cancer Research (AACR) is proud to offer Global Scholar-in-Training Awards (GSITA) to support the career development of meritorious early-career scientists from countries building cancer research capacities. The GSITA program, now in its fifth year, will bring promising scientists from 9 countries—Argentina, Brazil, China, Ethiopia, Ghana, India, Jordan, Malaysia, and South Africa—to participate in AACR Annual Meeting 2024 in San Diego.

Mutsa Takundwa, PhD

Council for Scientific and Industrial Research (CSIR), South Africa

Abstract 3074: 2D Tumor cell culture-based Ex-vivo drug sensitivity screening platform for South African patient samples (Leukemia, Multiple Myeloma and Ovarian cancer) demonstrate potential for targeted cancer therapies

Sofia Bruni

Instituto de Biologia y Medicina Experimental (IBYME-CONICET), Argentina

Abstract 3361: INB03: a new immune checkpoint inhibitor that reprograms macrophage polarization, boosts ADCP and reverts T-cell exhaustion markers

Li-Fang Yeo, PhD

Cancer Research Malaysia, Malaysia

Abstract 2617: Tumor microbiota associated with immune enrichment in breast tumor

Yvonne Nartey, MD, PhD

Cape Coast Teaching Hospital/University of Cape Coast, Ghana

Abstract 2220: Accuracy of the GALAD serologic model in the diagnosis of hepatocellular carcinoma in Ghanaian patients

Divpreet Kaur

Dr B.R. Ambedkar Center for Biomedical Research (ACBR), University of Delhi, India

Abstract 2833: Identification of novel lead compounds and repurposing FDA-approved drugs as telomerase inhibitors using a structure-based drug designing approach and their evaluation using in-vitro and ex-vivo assays

Diana Aguilar Cortes

Fundación Instituto Leloir, Argentina

Abstract 2060: Development of novel mono and bivalent nanobodies against EGFR for targeted cancer therapy

Viktor Kalbermatter Boell

Institute of Chemistry, University of Sao Paulo (USP), Brazil

Abstract 3198: DUSP12 in glioblastoma: Insights into nucleolar stress and DNA damage response

Seifegebriel Teshome Feleke

Addis Ababa University, Ethiopia

Abstract 2751: Profiling the CpG methylation patterns of Epstein-Barr Virus DNA in lymphoma patients from Ethiopia

Yucheng Dong

Peking Union Medical College, China

Abstract 3203: Single-cell sequencing identiﬁcation of malignant cell subpopulations linked to recurrence in hepatocellular carcinoma

Ankit Mathur, PhD

Delhi School of Public Health, Institution of Eminence, University of Delhi, India

Abstract 2932: Differentiation Therapy: Esculetin as a potent agent to alter cellular plasticity of leukemic and solid tumor stem cells

Balachander Kannan

Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India

Abstract 3049: Silencing of novel m6A reader PRRC2A as a therapeutic strategy for oral cancer

Gaston Pascual

University of Buenos Aires, (CONICET – IQUIBICEN), Argentina

Abstract 3138: Androgen receptor (CAG)n polymorphism: A genomic marker for prostate cancer prognosis independent of histopathological parameters

Yuli Thamires Magalhaes, PhD

Institute of Chemistry, University of Sao Paulo (USP), Brazil

Abstract 3145: Unraveling the Role of F-Actin in Resistant GBM: Insights into DNA Repair, GSC Phenotype, and Therapeutic Implications

Obada Ehab Ababneh

Jordan University of Science and Technology, Jordan

Abstract 2927: The predictive role of TNF-related genes in patients receiving immune checkpoint inhibitors

Mohammad Nitham Almajali

Jordan University of Science and Technology, Jordan

Abstract 3254: Exploring genetic determinants: A comprehensive analysis of SERPINB family variants and prognosis in Jordanian Glioblastoma Multiforme patients